Search clinical trials for: Ketamine Naltrexone

Total 1914 results

University of California, San Francisco

Completed

A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

Multiple Sclerosis

United States
VA Connecticut Healthcare System

Completed

Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Major Depressive Disorder | Alcohol Use Disorder
Denver Health and Hospital Authority

Completed

Inpatient Single Dose Interventions for Alcohol Use Disorder

Alcohol Use Disorder, Severe

United States
Stanford University
National Institute of Mental Health (NIMH)

Recruiting

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2) (MKET2)

Obsessive-Compulsive Disorder

United States
Erasmus Medical Center

Enrolling by invitation

Long-term Pain Modulation by Intravenous Esketamine in CRPS (KetCRPS-2)

Complex Regional Pain Syndromes | CRPS (Complex Regional Pain Syndromes)

Netherlands
Medical University of Vienna

Recruiting

Imaging Neural Correlates of Ketamine Using PET/MR (RSKet)

Major Depressive Disorder

Austria
San Diego State University

Recruiting

Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences

Placebo | Naltrexone

United States
VA Office of Research and Development

Completed

Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Major Depressive Disorder | Alcohol Use Disorder

United States
Juvenile Bipolar Research Foundation

Terminated

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder (IKBP)

Bipolar Disorder

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Alcohol Pharmacotherapy for HIV+ Prisoners (INSPIRE)

Alcohol Dependence | Human Immunodeficiency Virus | AIDS | Hazardous Drinking | Problem Drinking

United States
Alkermes, Inc.

Terminated

ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])

Alcoholism | Opiate Dependence
Alkermes, Inc.

Completed

ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults

Alcoholism
Janssen Research & Development, LLC

Completed

Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users

Drug Abuse

United States
Alkermes, Inc.

Completed

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Opiate Dependence
Tianjin Medical University General Hospital

Recruiting

S-ketamine Prevents Postoperative Pain and Cognitive Dysfunction After Tibial Fracture

Postoperative Pain | Postoperative Cognitive Dysfunction

China
University of Pennsylvania
National Institute on Drug Abuse (NIDA); St. Petersburg State Pavlov Medical...

Completed

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

Opioid-Related Disorders | Heroin Dependence

United States, Russian Federation
Fujian Provincial Hospital

Completed

Esketamine-propofol Versus Propofol for Flexible Bronchoscopy

Postoperative Recovery

China
University of Bern
University Hospital Inselspital, Berne

Completed

The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams

Neuroscience of Dreaming, Healthy

Switzerland
Turku University Hospital
University of Turku; University of Helsinki

Completed

Dose-response of Ketamine in Patient Controlled Analgesia in Orthopaedic Surgery Patients (DoseRespKeta)

Pain, Postoperative

Finland
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone and Memantine Effects on Alcohol Drinking Behaviors

Alcohol Drinking

United States
Zylorion Health

Withdrawn

Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study (ZYL-730-02)

Treatment Resistant Major Depressive Disorder
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Intranasal Naltrexone and Naloxone

Opioid-use Disorder
Lund University

Completed

Racemic Ketamine Versus S-ketamine With Arterial Spin Labeling (ASL)-MRI in Healthy Volunteers

Healthy | Abnormal Vascular Flow

Sweden
Centre for Addiction and Mental Health

Unknown

Vivitrol Treatment for Cannabis Use Disorder

Cannabis Use Disorder

Canada
State University of New York - Upstate Medical...
Cephalon

Completed

Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) (vivitrol)

Alcohol Dependence | Schizophrenia | Schizoaffective Disorders | Bipolar Disorders

United States
Eye & ENT Hospital of Fudan University

Completed

S-ketamin Premedication in Pediatric EENT Surgery

Pain, Procedural | Emotions | Separation Anxiety

China
Medical University of Lublin

Recruiting

Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia

Quality of Life | Vulvodynia | Naltrexone

Poland
The George Institute
The University of New South Wales

Recruiting

Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression (TREK)

Treatment Resistant Depression

Australia
Second Affiliated Hospital, School of Medicine,...

Recruiting

Intraoperative S-ketamine to Prevent Postoperative Hyperalgesia in Patients Undergoing Video-assisted Thoracic Surgery

Postoperative Hyperalgesia

China
Beijing Obstetrics and Gynecology Hospital
Obstetrics & Gynecology Hospital of Fudan University; Beijing Haidian Maternal... and other collaborators

Unknown

The Efficacy and Safety of S-ketamine in Elective Cesarean Section (ES-CS)

Depression | Analgesia | Cesarean Section | Anesthesia | Parturition
Yan Qiu

Unknown

The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT) (ECT)

Major Depressive Disorder | Depression, Unipolar | Depression, Bipolar | Manic-Depressive - Now Depressed

China
Dr. Inge Winter
Universität Münster

Recruiting

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. (INTENSIFY MDD)

Major Depressive Disorder | Treatment Resistant Depression

Austria, Germany, Italy, Spain, United Kingdom
Centre Hospitalier Universitaire de Charleroi
Centre Hospitalier Universitaire de Liege

Recruiting

Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome. (KESK-FIQ)

Fibromyalgia

Belgium
Zylorion Health

Terminated

Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression (ZYL-730-01)

Treatment Resistant Major Depressive Disorder

Canada
University of Colorado, Denver

Withdrawn

In Hospital IM Naltrexone: A Pilot Study (IM-NTX)

Alcohol Use Disorder
Albert Einstein Healthcare Network

Not yet recruiting

Bridging ED to Outpatient AUD Therapy With Naltrexone

Alcohol Use Disorder

United States
University of Chicago
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Efficacy of Naltrexone in Women's Smoking Cessation

Smoking | Smoking Cessation

United States
Jinnah Postgraduate Medical Centre

Completed

Efficacy of Low Dose Naltrexone in Psoriasis

Psoriasis

Pakistan
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Improved Strategies for Outpatient Opioid Detoxification

Opioid Dependence

United States
Drug Delivery Company, LLC DBA Akyso Pharmaceuticals
National Institute on Drug Abuse (NIDA); Laboratory Corporation of America; Cognitive...

Enrolling by invitation

Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults

Opioid Use Disorder

United States
Alkermes, Inc.

Completed

ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults

Alcoholism
Alkermes, Inc.

Completed

ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)

Alcoholism
University of Alabama at Birmingham

Withdrawn

Immune Effects of Low-dose Naltrexone in ME/CFS

Fatigue Syndrome, Chronic

United States
Yale University
National Institutes of Health (NIH)

Completed

Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia

Hypoglycemia

United States
Yale University
National Institute on Drug Abuse (NIDA); Baystate Medical Center

Completed

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (NewHope)

HIV | Opioid Dependence | AIDS | Drug Dependence

United States
University of Wisconsin, Madison

Completed

Attenuation of Pain in Men and Women

Pain

United States
US Department of Veterans Affairs

Terminated

Pilot Study of Depot NTX in Homeless Veterans

Alcohol Dependence

United States
Chinese PLA General Hospital
First Affiliated Hospital, Sun Yat-Sen University; Shengjing Hospital; First... and other collaborators

Not yet recruiting

Safety and Efficacy Evaluation of S (+) - Ketamine in Adults

Postoperative Pain | Anesthesia | Adults
Chinese PLA General Hospital
Shanghai Children's Medical Center; Beijing Children's Hospital; Southern Medical... and other collaborators

Enrolling by invitation

Safety and Efficacy Evaluation of S (+) - Ketamine in Children

Delirium | Postoperative Pain | Analgesia | Children | Acute Pain | Depression, Anxiety | Hyperalgesia | S-ketamine | Esketamine

China
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States

Search clinical trials for: Ketamine Naltrexone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations